Information

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm

Key Opinions in Medicine

  • Register
  • Login
Skip to content
  • Home
  • Issues
    • Allergy & Immunology
    • Cardiology
    • Conference
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes & Endocrinology
    • Gastroenterology
    • General Medicine
    • Haematology
    • Hepatology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Nursing
    • Obstetrics & Gynaecology
    • Oncology
    • Paediatrics
    • Psychiatry
    • Rheumatology
    • Surgery Insights
    • Urology
  • About
  • Contact
  • Register
  • Login

Figure 8. BALISTAD: Blocking IL-4 and IL-13 signaling normalized barrier TEWL in adults and adolescents99

Published November 16, 2022 at 2071 × 887 in Beyond the Skin Barrier – The Role of Type 2 Inflammation in Atopic Dermatitis Across the Ages.
← Previous
Figure 8. BALISTAD: Blocking IL-4 and IL-13 signaling normalized barrier TEWL in adults and adolescents99

Figure 8. BALISTAD: Blocking IL-4 and IL-13 signaling normalized barrier TEWL in adults and adolescents99

Figure 8. BALISTAD: Blocking IL-4 and IL-13 signaling normalized barrier TEWL in adults and adolescents99

Popular Issues

Konkurrenz für den Therapiestandard

MOVICOL® (PEG3350 plus electrolytes): 20 years of evidence-based use

Register

Register

Sign up for free access to Wiley’s Key Opinions in Medicine to keep up to date with latest trends and key developments within your specialty area.

Share

Copyright © 2000-2024 by John Wiley & Sons, Inc., or related companies. All rights reserved.
Review our privacy policy. Cookie Preferences.
Web design and marketing agency Leamington Spa